For neuromyelitis optica spectrum disorder, long-term follow-up with a second-generation complement inhibitor shows an unprecedented level of disease control at 3 years.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/long-term-control-neuromyelitis-optica-spectrum-disorder-2025a1000qk8?src=rss
Author :
Publish date : 2025-10-03 07:58:00
Copyright for syndicated content belongs to the linked Source.
